Bioforce Nanosciences HOLDINGS, Inc. (BFNH) intrinsic value & 10-year financials
Bioforce Nanosciences HOLDINGS, Inc. (BFNH) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $6.99
- Market cap
- $232.1M
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- 98.8%
- ROIC (10-yr avg)
- 11172.1%
- Free cash flow (FY2025)
- —
BFNH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$1.3M | -$0.04 | — | — | 88.5% |
| FY2024 | — | -$490.4K | -$0.02 | — | — | 23.8% |
| FY2023 | — | -$472.0K | -$0.02 | — | — | 29.8% |
| FY2022 | — | -$485.5K | -$0.02 | — | — | 44.0% |
| FY2021 | — | -$502.0K | — | — | — | 82.2% |
| FY2020 | — | -$158.4M | — | — | — | 101349.0% |
| FY2019 | $17.8K | -$46.5K | — | — | -261.8% | -120.7% |
| FY2018 | $16.3K | -$67.7K | — | — | -409.2% | -351.2% |
| FY2017 | $4.5K | -$31.3K | — | — | -694.7% | -596.2% |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
BIOFORCE NANOSCIENCES HOLDINGS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
BIOFORCE NANOSCIENCES HOLDINGS, INC. has earned high returns on invested capital, averaging 127.9% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
BIOFORCE NANOSCIENCES HOLDINGS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, BIOFORCE NANOSCIENCES HOLDINGS, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-1.33 per share.